• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首个经验证的德语版慢性炎症性肠病患者疲劳问卷的多中心评估

Multicenter Evaluation of the First Validated German-Language Fatigue Questionnaire for Patients with Chronic Inflammatory Bowel Diseases.

作者信息

Müller Magnus, Schulz Franziska, Tadic Vidan, Muzalyova Anna, Classen Johanna, Denzer Ulrike, Blumenstein Irina, Schnoy Elisabeth

机构信息

Internal Medicine III, Department of Gastroenterology, University Hospital Augsburg, 86156 Augsburg, Germany.

Medical Clinic 1, Frankfurt University Hospital, Goethe University Frankfurt, 60596 Frankfurt, Germany.

出版信息

J Clin Med. 2025 May 22;14(11):3618. doi: 10.3390/jcm14113618.

DOI:10.3390/jcm14113618
PMID:40507380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12155584/
Abstract

: Patients with inflammatory bowel disease (IBD) often suffer from extra-intestinal manifestations in addition to intestinal symptoms. One of these is fatigue. Fatigue is described as persistent tiredness with episodes of sudden energy loss, which cannot be relieved by rest or sleep and has a huge impact on quality of life. The aim of this study is to identify possible risk and influencing factors for the development of fatigue in IBD. : For this purpose, a questionnaire survey was conducted at two German university outpatient clinics for IBD (n = 164). Based on this, the frequency and impact of fatigue on daily life was assessed and analyzed in relation to various health parameters such as patient gender, age, disease activity, and laboratory parameters. : Of the 164 patients, 86 were men (52.4%) and 78 were women (47.6%). A total of 75 (45.7%) patients had ulcerative colitis, 84 (51.2%) suffered from Crohn's disease, and 5 (3.0%) had IBD-unclassified. A total of 17 out of the 164 (10.4%) patients denied that fatigue had affected their daily activities in the past two weeks. None of the examined health parameters had a significant impact on fatigue. : Fatigue is a common syndrome in IBD patients and affects their daily activities and quality of life. The results of the present study emphasize the need for further research for a better scientific understanding of fatigue in IBD.

摘要

炎症性肠病(IBD)患者除肠道症状外,还常伴有肠外表现。其中之一就是疲劳。疲劳被描述为持续的疲倦,并伴有突然的能量丧失发作,休息或睡眠无法缓解,对生活质量有巨大影响。本研究的目的是确定IBD患者发生疲劳的可能风险和影响因素。

为此,在德国两家大学的IBD门诊诊所进行了问卷调查(n = 164)。在此基础上,评估并分析了疲劳对日常生活的频率和影响,并与患者性别、年龄、疾病活动度和实验室参数等各种健康参数相关联。

164名患者中,86名男性(52.4%),78名女性(47.6%)。共有75名(45.7%)患者患有溃疡性结肠炎,84名(51.2%)患有克罗恩病,5名(3.0%)患有未分类的IBD。164名患者中有17名(10.4%)否认疲劳在过去两周影响了他们的日常活动。所检查的健康参数均未对疲劳产生显著影响。

疲劳是IBD患者常见的综合征,会影响他们的日常活动和生活质量。本研究结果强调需要进一步研究,以便更好地科学理解IBD患者的疲劳情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90a8/12155584/df53a80123a5/jcm-14-03618-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90a8/12155584/f9f29e3f750c/jcm-14-03618-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90a8/12155584/df53a80123a5/jcm-14-03618-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90a8/12155584/f9f29e3f750c/jcm-14-03618-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90a8/12155584/df53a80123a5/jcm-14-03618-g002.jpg

相似文献

1
Multicenter Evaluation of the First Validated German-Language Fatigue Questionnaire for Patients with Chronic Inflammatory Bowel Diseases.首个经验证的德语版慢性炎症性肠病患者疲劳问卷的多中心评估
J Clin Med. 2025 May 22;14(11):3618. doi: 10.3390/jcm14113618.
2
Depression influences fatigue in inflammatory bowel disease amongst other factors: a structural modelling approach.除其他因素外,抑郁症会影响炎症性肠病中的疲劳:一种结构建模方法。
Therap Adv Gastroenterol. 2024 Sep 2;17:17562848241271987. doi: 10.1177/17562848241271987. eCollection 2024.
3
Effectiveness and safety outcomes after long-term (54 weeks) vedolizumab therapy for Crohn's disease: a prospective, real-world observational study including patient-reported outcomes (POLONEZ II).维多珠单抗长期(54周)治疗克罗恩病后的有效性和安全性结果:一项前瞻性、真实世界观察性研究,纳入患者报告结局(POLONEZ II)
Therap Adv Gastroenterol. 2024 Nov 20;17:17562848241293938. doi: 10.1177/17562848241293938. eCollection 2024.
4
The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.2018年炎症性肠病对加拿大的影响:直接成本与医疗服务利用情况
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S17-S33. doi: 10.1093/jcag/gwy055. Epub 2018 Nov 2.
5
The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.2018年加拿大炎症性肠病的影响:炎症性肠病的肠外疾病
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S73-S80. doi: 10.1093/jcag/gwy053. Epub 2018 Nov 2.
6
Association of fatigue with disease activity and clinical manifestations in patients with Crohn's disease and ulcerative colitis: an observational cross-sectional study in the United States.炎症性肠病患者疲劳与疾病活动和临床表现的相关性:美国的一项观察性横断面研究。
Curr Med Res Opin. 2024 Sep;40(9):1537-1544. doi: 10.1080/03007995.2024.2380733. Epub 2024 Aug 1.
7
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
8
Assessing disease control in inflammatory bowel disease: a real world cross-sectional study in the UK (PODCAST-IBD).评估炎症性肠病的疾病控制:英国真实世界横断面研究(PODCAST-IBD)。
Curr Med Res Opin. 2024 Nov;40(11):1847-1854. doi: 10.1080/03007995.2024.2410928. Epub 2024 Oct 14.
9
Identifying and understanding disease burden in patients with inflammatory bowel disease.识别和了解炎症性肠病患者的疾病负担。
BMJ Open Gastroenterol. 2022 Oct;9(1). doi: 10.1136/bmjgast-2022-000994.
10
Supported online self-management versus care as usual for symptoms of fatigue, pain and urgency/incontinence in adults with inflammatory bowel disease (IBD-BOOST): study protocol for a randomised controlled trial.支持在线自我管理与常规护理对炎症性肠病(IBD-BOOST)成人疲劳、疼痛和急迫/失禁症状的影响:一项随机对照试验的研究方案。
Trials. 2021 Aug 3;22(1):516. doi: 10.1186/s13063-021-05466-4.

本文引用的文献

1
Fatigue in Inflammatory Bowel Disease: No Effect of Serum Concentrations of Infliximab, Adalimumab or Anti-Drug Antibodies During Maintenance Therapy.炎症性肠病中的疲劳:维持治疗期间英夫利昔单抗、阿达木单抗血清浓度或抗药物抗体无影响。
Scand J Immunol. 2025 May;101(5):e70029. doi: 10.1111/sji.70029.
2
Effectiveness and safety outcomes after long-term (54 weeks) vedolizumab therapy for Crohn's disease: a prospective, real-world observational study including patient-reported outcomes (POLONEZ II).维多珠单抗长期(54周)治疗克罗恩病后的有效性和安全性结果:一项前瞻性、真实世界观察性研究,纳入患者报告结局(POLONEZ II)
Therap Adv Gastroenterol. 2024 Nov 20;17:17562848241293938. doi: 10.1177/17562848241293938. eCollection 2024.
3
[Not Available].
[无可用内容]
Z Gastroenterol. 2024 Aug;62(8):1229-1318. doi: 10.1055/a-2309-6123. Epub 2024 Aug 7.
4
Physical Activity for Quiescent and Mildly Active Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.静止期和轻度活动期炎症性肠病的体育活动:一项系统评价和荟萃分析。
J Can Assoc Gastroenterol. 2023 Aug 10;6(5):162-171. doi: 10.1093/jcag/gwad021. eCollection 2023 Oct.
5
Effect of Vitamin D Supplementation on Fatigue in Multiple Sclerosis: A Systematic Review and Meta-Analysis.维生素 D 补充对多发性硬化症疲劳的影响:系统评价和荟萃分析。
Nutrients. 2023 Jun 24;15(13):2861. doi: 10.3390/nu15132861.
6
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAID.炎症性肠病患者疲劳的患病率及其决定因素:来自GETAID的横断面调查
J Crohns Colitis. 2023 Oct 20;17(9):1418-1425. doi: 10.1093/ecco-jcc/jjad060.
7
Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial.铁源性葡聚糖和羧基麦芽糖铁治疗炎症性肠病相关缺铁性贫血患者后出现低磷血症(PHOSPHARE-IBD):一项随机临床试验。
Gut. 2023 Apr;72(4):644-653. doi: 10.1136/gutjnl-2022-327897. Epub 2022 Sep 9.
8
Validation of the German Inflammatory Bowel Disease Fatigue (IBD-F) Questionnaire.验证德国炎症性肠病疲劳(IBD-F)问卷。
Z Gastroenterol. 2023 Feb;61(2):164-171. doi: 10.1055/a-1797-2688. Epub 2022 May 9.
9
Fatigue in patients with chronic disease: results from the population-based Lifelines Cohort Study.慢性病患者的疲劳:基于人群的 Lifelines 队列研究的结果。
Sci Rep. 2021 Oct 25;11(1):20977. doi: 10.1038/s41598-021-00337-z.
10
Long-term maintenance treatment with 300 mg thiamine for fatigue in patients with inflammatory bowel disease: results from an open-label extension of the TARIF study.一项开放标签扩展研究:300 毫克硫胺素治疗炎症性肠病患者疲劳的长期维持治疗:TARIF 研究结果。
Scand J Gastroenterol. 2022 Jan;57(1):37-43. doi: 10.1080/00365521.2021.1983640. Epub 2021 Sep 30.